AVXL
Price
$10.98
Change
-$0.08 (-0.72%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
937.88M
24 days until earnings call
TENX
Price
$5.96
Change
+$0.08 (+1.36%)
Updated
Jul 18, 04:57 PM (EDT)
Capitalization
24.73M
Interact to see
Advertisement

AVXL vs TENX

Header iconAVXL vs TENX Comparison
Open Charts AVXL vs TENXBanner chart's image
Anavex Life Sciences
Price$10.98
Change-$0.08 (-0.72%)
Volume$30.23K
Capitalization937.88M
Tenax Therapeutics
Price$5.96
Change+$0.08 (+1.36%)
Volume$125
Capitalization24.73M
AVXL vs TENX Comparison Chart in %
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. TENX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and TENX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (AVXL: $11.06 vs. TENX: $5.88)
Brand notoriety: AVXL and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 61% vs. TENX: 47%
Market capitalization -- AVXL: $937.88M vs. TENX: $24.73M
AVXL [@Biotechnology] is valued at $937.88M. TENX’s [@Biotechnology] market capitalization is $24.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileTENX’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • TENX’s FA Score: 1 green, 4 red.
According to our system of comparison, TENX is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 3 TA indicator(s) are bullish while TENX’s TA Score has 5 bullish TA indicator(s).

  • AVXL’s TA Score: 3 bullish, 4 bearish.
  • TENX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, TENX is a better buy in the short-term than AVXL.

Price Growth

AVXL (@Biotechnology) experienced а -1.07% price change this week, while TENX (@Biotechnology) price change was +1.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

AVXL is expected to report earnings on Dec 22, 2025.

TENX is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($938M) has a higher market cap than TENX($24.7M). AVXL YTD gains are higher at: 2.980 vs. TENX (-5.008). TENX has higher annual earnings (EBITDA): -24.2M vs. AVXL (-45.65M). AVXL (116M) and TENX (111M) have equal amount of cash in the bank . AVXL has less debt than TENX: AVXL (88.2K) vs TENX (279K). AVXL (0) and TENX (0) have equivalent revenues.
AVXLTENXAVXL / TENX
Capitalization938M24.7M3,798%
EBITDA-45.65M-24.2M189%
Gain YTD2.980-5.008-59%
P/E RatioN/A3.53-
Revenue00-
Total Cash116M111M105%
Total Debt88.2K279K32%
FUNDAMENTALS RATINGS
AVXL vs TENX: Fundamental Ratings
AVXL
TENX
OUTLOOK RATING
1..100
172
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3846
P/E GROWTH RATING
1..100
10053
SEASONALITY SCORE
1..100
n/a26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TENX's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for AVXL (62) in the Biotechnology industry. This means that TENX’s stock grew somewhat faster than AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (78) in the Biotechnology industry is in the same range as TENX (100) in the Medical Specialties industry. This means that AVXL’s stock grew similarly to TENX’s over the last 12 months.

AVXL's SMR Rating (97) in the Biotechnology industry is in the same range as TENX (97) in the Medical Specialties industry. This means that AVXL’s stock grew similarly to TENX’s over the last 12 months.

AVXL's Price Growth Rating (38) in the Biotechnology industry is in the same range as TENX (46) in the Medical Specialties industry. This means that AVXL’s stock grew similarly to TENX’s over the last 12 months.

TENX's P/E Growth Rating (53) in the Medical Specialties industry is somewhat better than the same rating for AVXL (100) in the Biotechnology industry. This means that TENX’s stock grew somewhat faster than AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLTENX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 19 days ago
80%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWGSX28.540.28
+0.99%
Nationwide WCM Focused Sm Cp Instl Svc
PIIDX14.950.13
+0.88%
Principal International Equity R-6
BIOPX52.250.40
+0.77%
Baron Opportunity Retail
GFFDX86.650.25
+0.29%
Invesco Global Focus R5
AZMIX18.14N/A
N/A
Virtus NFJ Emerging Markets Value Ins

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
-1.78%
PLRX - AVXL
48%
Loosely correlated
+5.97%
RXRX - AVXL
47%
Loosely correlated
+5.75%
TENX - AVXL
47%
Loosely correlated
+0.51%
AXON - AVXL
45%
Loosely correlated
+0.42%
MNMD - AVXL
42%
Loosely correlated
+3.50%
More

TENX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been loosely correlated with AVXL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TENX jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
+0.51%
AVXL - TENX
47%
Loosely correlated
-1.78%
SBHMY - TENX
42%
Loosely correlated
N/A
CORT - TENX
41%
Loosely correlated
+0.34%
ADVM - TENX
36%
Loosely correlated
N/A
COYA - TENX
30%
Poorly correlated
+2.94%
More